These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 11465692)

  • 1. Mergers in the publishing industry.
    Lipscomb CE
    Bull Med Libr Assoc; 2001 Jul; 89(3):307-8. PubMed ID: 11465692
    [No Abstract]   [Full Text] [Related]  

  • 2. A new policy on financial disclosure.
    Nat Neurosci; 2001 Oct; 4(10):961. PubMed ID: 11574824
    [No Abstract]   [Full Text] [Related]  

  • 3. Connections between open access publishing and access to gray literature.
    Banks M
    J Med Libr Assoc; 2004 Apr; 92(2):164-6. PubMed ID: 15088074
    [No Abstract]   [Full Text] [Related]  

  • 4. Study discloses financial interests behind papers.
    Wadman M
    Nature; 1997 Jan; 385(6615):376. PubMed ID: 9009171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 6. Open access publishing, NIH policy and the Journal of Clinical Sleep Medicine.
    Quan SF
    J Clin Sleep Med; 2005 Jul; 1(3):233-4. PubMed ID: 17566181
    [No Abstract]   [Full Text] [Related]  

  • 7. Declaration of financial interests.
    Campbell P
    Nature; 2001 Aug; 412(6849):751. PubMed ID: 11518924
    [No Abstract]   [Full Text] [Related]  

  • 8. Business as usual.
    Nat Biotechnol; 2001 Oct; 19(10):891-2. PubMed ID: 11581636
    [No Abstract]   [Full Text] [Related]  

  • 9. Declaration of financial interests.
    Campbell P
    Nat Biotechnol; 2001 Oct; 19(10):892. PubMed ID: 11581637
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigating journals: The dark side of publishing.
    Butler D
    Nature; 2013 Mar; 495(7442):433-5. PubMed ID: 23538810
    [No Abstract]   [Full Text] [Related]  

  • 11. Public access to biomedical research.
    Drazen JM; Curfman GD
    N Engl J Med; 2004 Sep; 351(13):1343. PubMed ID: 15385662
    [No Abstract]   [Full Text] [Related]  

  • 12. A look inside the Pharos review process.
    Harris ED
    Pharos Alpha Omega Alpha Honor Med Soc; 2003; 66(2):36-7. PubMed ID: 12838637
    [No Abstract]   [Full Text] [Related]  

  • 13. The crisis in scholarly publishing: open access to the rescue?
    Oren GA
    J Neuroophthalmol; 2008 Mar; 28(1):1-4. PubMed ID: 18347450
    [No Abstract]   [Full Text] [Related]  

  • 14. Avoid financial 'correctness'.
    Nature; 1997 Feb; 385(6616):469. PubMed ID: 9020340
    [No Abstract]   [Full Text] [Related]  

  • 15. Reporting clinical trials: full access to all the data.
    Epilepsia; 2001 Dec; 42(12):1492-3. PubMed ID: 11879357
    [No Abstract]   [Full Text] [Related]  

  • 16. Nothing to see here.
    Nat Biotechnol; 2008 May; 26(5):476. PubMed ID: 18464755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial associations of authors.
    Relman AS
    N Engl J Med; 2002 Sep; 347(13):1043-4; author reply 1043-4. PubMed ID: 12324569
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial associations of authors.
    Bittl JA
    N Engl J Med; 2002 Sep; 347(13):1043-4; author reply 1043-4. PubMed ID: 12353516
    [No Abstract]   [Full Text] [Related]  

  • 19. A really serious conflict.
    Nat Med; 2009 May; 15(5):463-4. PubMed ID: 19424181
    [No Abstract]   [Full Text] [Related]  

  • 20. Open access to research is in the public interest.
    Engelward BP; Roberts RJ
    PLoS Biol; 2007 Feb; 5(2):e48. PubMed ID: 17298181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.